(Q48937136)

17 February 2018

title

Nitric oxide involvement in the anxiogenic-like effect of substance P. (English)

1 reference

17 February 2018

0 references

Baretta IP

1

1 reference

17 February 2018

Assreuy J

series ordinal

2

1 reference

17 February 2018

De Lima TC

series ordinal

3

1 reference

17 February 2018

language of work or name

English

0 references

publication date

1 June 2001

1 reference

17 February 2018

Behavioural Brain Research

published in

1 reference

17 February 2018

volume

121

1 reference

17 February 2018

issue

1-2

1 reference

17 February 2018

page(s)

199-205

1 reference

17 February 2018

Effects of microinjections of the neuropeptide substance P in the dorsal periaqueductal gray on the behaviour of rats in the plus-maze test.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Neurochemical mechanisms of the defensive behavior in the dorsal midbrain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Nitric oxide synthase activity in the dorsal periaqueductal gray of rats expressing innate fear responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Polyamines inhibit N-methyl-D-aspartate antagonist-induced darting behavior in the rat prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Central tachykinins: mediators of defence reaction and stress reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

The nitric oxide synthase inhibitor 7-nitroindazole displays enhanced anxiolytic efficacy without tolerance in rats following subchronic administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Anxiogenic effects of substance P and its 7-11 C terminal, but not the 1-7 N terminal, injected into the dorsal periaqueductal gray.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Effects of L-NOARG on plus-maze performance in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Anxiolytic effect of methylene blue microinjected into the dorsal periaqueductal gray matter.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Acute inhibition of nitric oxide synthesis induces anxiolysis in the plus maze test.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Anxiolytic action of a neurokinin1 receptor antagonist in the social interaction test.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Nitric oxide signaling in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Anxiogenic-like effect induced by substance P injected into the lateral septal nucleus.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Nitric oxide mediates long-term hyperalgesic and antinociceptive effects of the N-terminus of substance P in the formalin assay in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Anxiolytic effect of nitric oxide synthase inhibitors microinjected into the dorsal central grey

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Anxiolytic-like action of neurokinin substance P administered systemically or into the nucleus basalis magnocellularis region.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

A search for brain stem cell groups integrating the defence reaction in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

5-Hydroxytryptamine-facilitated release of substance P from rat spinal cord slices is mediated by nitric oxide and cyclic GMP.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Substance P augments nitric oxide production and gene expression in murine macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Role of nitric oxide in central synaptic transmission: effects on neurotransmitter release.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Long-term potentiation in the hippocampal CA1 region of mice lacking cGMP-dependent kinases is normal and susceptible to inhibition of nitric oxide synthase.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Nitric oxide synthases in mammals

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Intracerebroventricular injections in mice. Some methodological refinements

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Brain iNOS: current understanding and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Endogenous nitric oxide modulates behavioural effects elicited by substance P in rat

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

The L-arginine-nitric oxide pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Discovery of some of the biological effects of nitric oxide and its role in cell signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Inhibition of nitric oxide synthase reduces ultrasonic vocalizations of rat pups

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Tachykinin NK(3)receptor involvement in anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Naloxone-induced changes in tachykinin NK3 receptor modulation of experimental anxiety in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Animal models of anxiety: an ethological perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Pharmacological blockade or genetic deletion of substance P (NK(1)) receptors attenuates neonatal vocalisation in guinea-pigs and mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

The tachykinin NK1 receptor in the brain: pharmacology and putative functions

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Modulation of N-methyl-D-aspartate (NMDA) antagonist-induced darting behaviour by the peptidomimetic PAMTA

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Evidence that substance P is utilized in medial amygdaloid facilitation of defensive rage behavior in the cat.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Induction of Fos immunoreactivity in the brain by exposure to the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

The nitric oxide-cyclic GMP signalling pathway in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Substance P induces a cardiovascular defense reaction in the rat: pharmacological characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Histochemical mapping of nitric oxide synthase in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Inhibition of nitric oxide synthase causes anxiolytic-like behaviour in an elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

L-Arginine abolishes the anxiolytic-like effect of diazepam in the elevated plus-maze test in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-4328%2801%2900165-6

7 January 2021

10.1016/S0166-4328(01)00165-6

Identifiers

DOI

1 reference

17 February 2018

PubMed ID

11275297

1 reference

17 February 2018